Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2. - Wikidata - wikimedia - TriplyDB

Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.

Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.

http://www.wikidata.org/entity/Q38844903

about

An overview of cutaneous T cell lymphomas New developments in the pathology of malignant lymphoma: a review of the literature published from May 2015–September 2015 Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?Checkpoint inhibitors in hematological malignancies The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents.Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.Analysis of differential β variable region of T cell receptor expression and NAV3/TNFRSF1B gene mutation in mycosis fungoides Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB.Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover Exogenous expression of SAMHD1 inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells.Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome.Sézary syndrome: old enigmas, new targets.Clinical manifestations and pathogenesis of cutaneous lymphomas: current status and future directions.Sézary Syndrome: Clinical and Biological Aspects.Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.The biomarker landscape in mycosis fungoides and Sézary syndrome.Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders.Genetic alterations in adult T-cell leukemia/lymphoma.Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators.NRAS mutations in cutaneous T cell lymphoma (CTCL) sensitize tumors towards treatment with the multikinase inhibitor Sorafenib.A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma.TruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform.ONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-κB pathways.Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.The Genetic Basis of Hepatosplenic T-cell Lymphoma.Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.TNFR2: The new Treg switch?Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients.A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas.Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E).Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome.Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors.A retrospective comparative outcome analysis following systemic therapy in Mycosis fungoides and Sezary syndrome.

P2860

Q26740306-AA7E4725-65C7-49E6-8E77-8C393FE4DFEB Q26774077-73791BC6-DCB2-4F10-94CC-53F1E67F40A8 Q27027493-13A73103-440D-4BA5-9893-36F1EF8252F6 Q30239965-A237F0A8-A86F-42E2-B5BD-54CA9BF092EA Q33651495-116423D0-2A91-4438-B776-E68B0320E37D Q34501143-A715BF92-1797-4255-9C42-8B0F62EF4CA7 Q34516083-224A2B21-AB64-4928-B9F4-B753F1783C58 Q36372043-BDC89FA4-5A65-4E6A-8DEE-50ED5D4C1201 Q36793430-42319999-CE40-49EC-B4F2-419A16D115DF Q36940326-46DF8FA6-8E11-4031-A1E7-D165031DEBF2 Q36998864-26F26E12-46AC-4E86-BE55-B7E9F289D124 Q37109658-E7967C57-5124-45C8-B54E-8101ED3E583D Q37237891-D13A9090-8595-4C15-9862-16ACA7B940BF Q37262461-2910EE16-73A9-4016-9DAE-55D907A03708 Q37702571-8407194A-03DC-4C18-A0CD-300905738108 Q37723390-08BF5F3D-84ED-4DA4-8D7F-CAF16C73958E Q38727148-A4DF18C6-0E3B-478D-A64E-309A603F11EE Q38765889-DF056A0E-C04B-4B04-9EAE-713D56C9A674 Q38772711-5257E19C-6986-4DC1-9218-B1C36F836F46 Q38805440-4A229DE2-4627-4B80-827C-F7FC70067759 Q38814744-07101C2C-A7EE-4CE2-80AC-DDBAD777BF81 Q38855013-AEC50B1F-B74A-4206-8F82-69F03196715A Q39023382-D6E57810-5B3A-4C67-8E78-D6A2D8EC3F17 Q39055861-03D500BC-C14C-4543-B47B-1C78C5FAA9CE Q39382494-0D86F51F-EBDF-4FF6-8F6B-AD8398F86B4F Q40150337-8BDCD524-E4C7-48B6-A684-C40DF169054D Q41233629-62172A71-FF02-4667-8BB6-3328A1BF49DE Q41288484-78B04D22-CECB-4FFE-B0EE-94C74EC758E7 Q42270898-2D20AEF5-E43F-402E-9E93-23E68C6B621A Q42365296-44299549-58AE-4040-9257-86C80D85F57C Q42397480-68FD7E26-C166-482D-8F50-C0DE89856E98 Q46356479-F25C7869-3C73-4DEF-B8E6-5364C0E3F796 Q47359072-FDA8BCBF-0958-4B06-B1C4-E5625B910D05 Q47381937-0B281355-41BA-4047-8D63-D16EDF9BB2B3 Q47567993-5BAFDFE6-3841-4862-8033-2961CB53A55C Q47902760-ED1A0D55-170C-4A03-A05F-250C3B7C55C5 Q48149767-2EB5DBF1-DD45-4698-AB87-1036584CE740 Q48296904-0FE1C679-1D6D-493F-B3E7-C85507CAD5E3 Q50938874-F8491527-780F-4837-BF65-30F6BC110620 Q51484852-8CBBB6DE-E469-4609-8C66-1E8B2A13268E

P2860

Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.

http://www.wikidata.org/entity/Q38844903

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Genomic analysis of mycosis fu ...... ecurrent alterations in TNFR2.

@en

type

label

Genomic analysis of mycosis fu ...... ecurrent alterations in TNFR2.

@en

prefLabel

Genomic analysis of mycosis fu ...... ecurrent alterations in TNFR2.

@en

P1433

Q38844903-6DC85FC1-EAC8-4041-81A5-21B6E31772FE

P1476

Q38844903-E23E469F-0F24-42F4-900E-921597E23FE2

P2093

Q38844903-0DE7B06F-025A-40AD-973C-47FF9B06DA0F

Q38844903-2CF9573B-2105-4FC1-AF38-DC1307458D91

Q38844903-2DB7521B-22B8-43B2-A75C-0C4B780DBBFD

Q38844903-3EA1BC68-5703-43F4-9C24-82EDA4254BF1

Q38844903-70396BEB-677D-4DF0-B6AC-A6D5C7559C38

Q38844903-70754B24-BEBB-4678-B125-6A4345B0B276

Q38844903-95171EC4-07CB-4DB0-B4B5-543B906BCA23

Q38844903-A03FE95C-EFC8-4E0C-A78A-8F72256964B0

Q38844903-B7B5723E-CF9F-47BC-919E-8B435A52CC2F

Q38844903-B7F389BA-20F0-4B82-B5E1-6B503D645C85

P2860

Q38844903-1485881E-C0A0-4934-88CC-880BC29AEC94

Q38844903-1612F912-68DD-46A1-B162-BBDB3077A4C2

Q38844903-184F0989-51AA-485F-96D6-EAB6338E9A67

Q38844903-1C36B92B-889A-415A-96C4-3E0B30B4DDA5

Q38844903-292D885E-0C8C-4565-868B-5FA7CF5C2224

Q38844903-31A9FBB5-9865-4E09-828E-7B80997C175B

Q38844903-32B54DB0-5628-429F-B8A9-818EC77B2486

Q38844903-381BDF0C-A32D-420E-8564-2454EDCA67B1

Q38844903-4FE44AAA-DF40-4AA1-942B-EDE7CC255B7E

Q38844903-5DDECC3C-EC27-4FA6-9D21-3813BF36DEDC

P2888

Q38844903-F9E108FC-687F-424D-95F3-B4B5FA08398F

P304

Q38844903-5473AFAC-E250-47A8-81FC-1DEE15D250FF

P31

Q38844903-58F8F26F-2945-4B7A-9044-24AB88804E83

P356

Q38844903-0E00789E-7219-46AE-9418-601E8CE576FC

P407

Q38844903-C27AD13C-1A45-4133-BECF-D494D388A0CC

P433

Q38844903-F29E77D8-AC0B-4AF9-B096-0A690B5AA46B

P478

Q38844903-F91E6066-198F-4925-9B96-2E50720F4ED2

P50

Q38844903-89854B3E-65D9-4F38-823F-43CE66B4ABB2

Q38844903-BC4C7B1B-0984-42DB-8C1A-D2F17B62BBB2

Q38844903-E87560BE-9C70-418E-A02E-3A7C02CC7874

Q38844903-FD938009-2C04-404B-AA6B-D4F7DBBD6378

P577

Q38844903-939CF0A1-FB62-4C20-B256-CD70A6024A0D

P6179

Q38844903-0B9C6307-7FAF-4BB0-91E2-ED59DA06D319

P698

Q38844903-4FDCBCD6-482D-4D66-93B0-6B6F26A26CA4

P932

Q38844903-F5AD82A5-8260-44A0-A8CE-6445CA0A7E75

P356

P1433

Nature Genetics

P1476

Genomic analysis of mycosis fu ...... ecurrent alterations in TNFR2.

@en

P2093

Alain Rook

http://www.w3.org/2001/XMLSchema#string

Alexander Ungewickell

http://www.w3.org/2001/XMLSchema#string

Angela Mah

http://www.w3.org/2001/XMLSchema#string

Aparna Bhaduri

http://www.w3.org/2001/XMLSchema#string

Ashley Zehnder

http://www.w3.org/2001/XMLSchema#string

Eon Rios

http://www.w3.org/2001/XMLSchema#string

Jason Reuter

http://www.w3.org/2001/XMLSchema#string

Michael Snyder

http://www.w3.org/2001/XMLSchema#string

Paul A Khavari

http://www.w3.org/2001/XMLSchema#string

Randall Armstrong

http://www.w3.org/2001/XMLSchema#string

P2860

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions

Multiplex genome engineering using CRISPR/Cas systems

Targeted capture and massively parallel sequencing of 12 human exomes

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

Death receptors: signaling and modulation

Fast and accurate long-read alignment with Burrows-Wheeler transform

A framework for variation discovery and genotyping using next-generation DNA sequencing data

Cancer immunotherapy comes of age

Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma.

dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations.

P2888

P304

1056-1060

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NG.3370

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Dita Gratzinger

Mahkam Tavallaee

Shashikant Kulkarni

P577

2015-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1034745696

http://www.w3.org/2001/XMLSchema#string

P698

26258847

http://www.w3.org/2001/XMLSchema#string

P932

6091217

http://www.w3.org/2001/XMLSchema#string